SCHEDULE: Atomico Advisors Discloses Hinge Health Stake

Atomico Advisors IV, Ltd. and its affiliates have reported beneficial ownership of 2,300,000 shares of Hinge Health, Inc. Class A Common Stock, representing 2.88% of the class.

Summary

• Atomico Advisors IV, Ltd., along with its affiliates Atomico IV, L.P. and Atomico IV (Guernsey), L.P., have filed a Schedule 13G, indicating their beneficial ownership of Hinge Health, Inc. Class A Common Stock.
• The total number of shares beneficially owned is 2,300,000.
• This holding represents 2.88% of the total outstanding Class A Common Stock.
• The shares are held subject to share collar contracts dated December 8, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an investment firm and does not provide new operational or financial performance data for Hinge Health, Inc.

Positives

• Atomico Advisors IV, Ltd. and its affiliates maintain a significant stake in Hinge Health, Inc., indicating continued confidence or investment interest.
• The filing clearly outlines the beneficial ownership structure and the percentage of the class held.

Negatives

• The filing does not contain any negative financial or operational information about Hinge Health, Inc. itself, as it is a disclosure of beneficial ownership by a third party.

Risks

• The shares held by Atomico IV L.P. and Atomico IV (Guernsey), L.P. are subject to share collar contracts, which may limit their flexibility or participation in certain price movements.
• The filing is an amendment (Amendment No. 2), suggesting ongoing changes or adjustments to the reporting persons' holdings or the underlying share count.

Future Outlook

The filing itself is a historical disclosure of beneficial ownership and does not contain forward-looking statements or guidance from Hinge Health, Inc. The share collar contracts may imply certain expectations or hedging strategies by Atomico Advisors.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and significant shareholders. The involvement of a prominent venture capital firm like Atomico Advisors in Hinge Health, a company in the digital health sector, aligns with broader investment trends in health technology. The use of share collar contracts is a common financial strategy for managing large equity positions.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding a significant shareholder's holdings, which can influence market perception.
• Investors: Provides insight into the investment strategy and holdings of Atomico Advisors in the digital health sector.

Next Steps

• Continued monitoring of Atomico Advisors' stake in Hinge Health, Inc.
• Review of future Hinge Health, Inc. filings for any changes in ownership or operational performance.

Key Dates

Keywords

Hinge Health, Schedule 13G, Atomico Advisors, Beneficial Ownership, Class A Common Stock, Share Collar Contract, SEC Filing, Investment Disclosure